Novel Automated Device Cultures Heart Stem Cells
A French start-up has designed and developed an automated device to culture heart stem cells. This might be an alternative to a heart transplant for 1 million patients in the main Western countries.
CellProthera, Pioneer in Cell Regenerative Therapy, Awarded the 2014 UBISTART Prize
A therapeutic approach to severe myocardial infarction, for which one million patients each year would be eligible
Long-term benefit of intracardiac delivery of autologous granulocyte–colony stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. Pasquet S , Sovalat H , Hénon Ph , et al. Cytotherapy, vol. 11, N°8,